載入...
High-Dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia
OBJECTIVE: Use of high-dose cyclophosphamide without hematopoietic stem cell transplant (HSCT) to treat severe aplastic anemia (SAA) has been controversial due to concern for increased infectious toxicity as compared to anti thymocyte globulin (ATG) and cyclosporine (CSA). As children often tolerate...
Na minha lista:
| 發表在: | J Pediatr Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5074865/ https://ncbi.nlm.nih.gov/pubmed/27467367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000647 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|